Despite earlier this month announcing its considering a sale of ADHD offerings, Shire has launched its latest Adderall formulation in the U.S. The company on Monday started selling Mydayis at a price of $271 per month before rebates and discounts, hoping to achieve $500 million in annual sales.
Shire had been marketing its new medication on a limited basis, but nowthe rollout has begun in earnest. It includes a copay offer for commercially insured patients, according to a release. In an interview, Shires head of global communications for ophthalmics and neuroscience, Clotilde Houz, said the launch provides the ADHD community a new treatment option.
We know that not all patients respond to medications in the same way, Houz said. We really want to support physicians and patients who might want different treatment options.
Mydayis won approval back in June based on 16 clinical trials incorporating more than 1,600 participants. The once-daily medication helped patients scores on a validated attention test, with effects starting within 2 to 4 hours and lasting up to 16 hours, according to the drugmaker. Mydayis is approved for ADHD patients 13 and older.
RELATED: Can Shire's new Mydayis, its latest Adderall iteration, really nab $500M in sales?
Weve been working since the FDA approval to properly train our salesforce and make sure that they have all of the information needed to talk to the physicians, Houz said, without disclosing how many representatives are supporting the launch.
She added that the 16-hour effect for Mydayis may be a benefit physicians seek out for treating their patients.
Sales expectations are mixed on the new drug, with the companys own thoughts coming in ahead of Wall Streets. At the time of approval, consensus analyst projections were for $288 million in sales by 2020, significantly short of Shires aspirations of $500 million for that year.
Shire priced its drug competitively and in consideration of the innovation and value it delivers, according to a company statement. Payer negotiations are ongoing, Houz said, adding that the company looks forward to sharing more news on that in the future.
To reach its $500 million sales ambition for 2020, Shire has said itll lean on its leadership position and experience in ADHD. Since the FDA approval for Mydayis, however, the Irish drugmaker has disclosed it may be looking to get out of neuroscience altogether.
RELATED: Shire hints at ADHD spinoff, but could someone step in and buy the neuro franchise?
In its second-quarter earnings announcement, the drugmaker disclosed its assessing strategic options for the group, potentially including an independent public listing. During the quarter, Vyvanse sales stayed flat versus the prior year at $518 million, while Adderall XR slipped 30% to $71 million.
Mydayis FDA approval followed a green light at the agency for Neos Therapeutics Cotempla, an extended-release ADHD drug that melts in the mouth. More than 10 million adults have ADHD in the U.S., according to Shire.
The company will continue its disease awareness campaign, but because Mydayis is a class 2 stimulant, Shire needs to await FDA guidance for DTC advertising, Houz said.
The rest is here:
Shire launches new ADHD drug Mydayis as it weighs a neuroscience exit - FiercePharma
- Marcus Neuroscience Institute to Host Brain and Spine Symposium - South Florida Hospital News - March 30th, 2025 [March 30th, 2025]
- Elon University to launch neuroscience major in fall 2025 - Today at Elon - March 30th, 2025 [March 30th, 2025]
- The brains stalwart sentinels express an unexpected gene - The Transmitter: Neuroscience News and Perspectives - March 30th, 2025 [March 30th, 2025]
- Video catches microglia in the act of synaptic pruning - The Transmitter: Neuroscience News and Perspectives - March 30th, 2025 [March 30th, 2025]
- Null and Noteworthy: Reexamining registered reports - The Transmitter: Neuroscience News and Perspectives - March 30th, 2025 [March 30th, 2025]
- Accepting the bitter lesson and embracing the brains complexity - The Transmitter: Neuroscience News and Perspectives - March 30th, 2025 [March 30th, 2025]
- NIH neurodevelopmental assessment system now available as iPad app - The Transmitter: Neuroscience News and Perspectives - March 30th, 2025 [March 30th, 2025]
- Stronger Bonds Before Birth Shape Healthier Mother-Child Futures - Neuroscience News - March 30th, 2025 [March 30th, 2025]
- How Emotionally Intelligent People Learn to Control Their Inner Voice, Backed by Neuroscience - Inc. - March 30th, 2025 [March 30th, 2025]
- Gabriele Scheler reflects on the interplay between language, thought and AI - The Transmitter: Neuroscience News and Perspectives - March 30th, 2025 [March 30th, 2025]
- Worlds first crowd-sourced neuroscience study aims to understand how our brains predict the future - EurekAlert - March 15th, 2025 [March 15th, 2025]
- Rewriting Neuroscience: Possible Foundations of Human Intelligence Observed for the First Time - SciTechDaily - March 15th, 2025 [March 15th, 2025]
- Calculating neurosciences carbon cost: Q&A with Stefan Pulver and William Smith - The Transmitter: Neuroscience News and Perspectives - March 15th, 2025 [March 15th, 2025]
- The future of neuroscience research at U.S. minority-serving institutions is in danger - The Transmitter: Neuroscience News and Perspectives - March 15th, 2025 [March 15th, 2025]
- Dopamine and social media: Why you cant stop scrolling, according to neuroscience - PsyPost - March 15th, 2025 [March 15th, 2025]
- Neuroscience Discovered a Clever Trick for Squeezing More Joy Out of Everyday Pleasures - Inc. - March 15th, 2025 [March 15th, 2025]
- The limits of neuroscience - The Transmitter: Neuroscience News and Perspectives - March 15th, 2025 [March 15th, 2025]
- BPOM Explains The Benefits Of Fasting From The Health And Neuroscience Side - VOI English - March 15th, 2025 [March 15th, 2025]
- How tiny tardigrades could help tackle systems neuroscience questions - The Transmitter: Neuroscience News and Perspectives - March 15th, 2025 [March 15th, 2025]
- Alison Preston explains how our brains form mental frameworks for interpreting the world - The Transmitter: Neuroscience News and Perspectives - March 15th, 2025 [March 15th, 2025]
- The Mystical Mind Meets Neuroscience: Seeking the Roots of Consciousness - Next Big Idea Club Magazine - March 15th, 2025 [March 15th, 2025]
- Myosin Therapeutics Closes Second Seed Round to Advance Clinical Trials for Innovative Cancer and Neuroscience Therapies - PR Newswire - March 5th, 2025 [March 5th, 2025]
- Neuroscience Ph.D. programs adjust admissions in response to U.S. funding uncertainty - The Transmitter: Neuroscience News and Perspectives - March 5th, 2025 [March 5th, 2025]
- New tools help make neuroimaging accessible to more researchers - The Transmitter: Neuroscience News and Perspectives - March 5th, 2025 [March 5th, 2025]
- Future Thinking Training Reduces Impulsivity - Neuroscience News - March 5th, 2025 [March 5th, 2025]
- Null and Noteworthy, relaunched: Probing a schizophrenia biomarker - The Transmitter: Neuroscience News and Perspectives - March 5th, 2025 [March 5th, 2025]
- How to communicate the value of curiosity-driven research - The Transmitter: Neuroscience News and Perspectives - March 5th, 2025 [March 5th, 2025]
- Cognitive neuroscience approach to explore the impact of wind turbine noise on various mental functions - Nature.com - March 5th, 2025 [March 5th, 2025]
- Football on the Brain: Helping coaches embed neuroscience knowledge - Training Ground Guru - March 5th, 2025 [March 5th, 2025]
- Taking Control: Using Neuroscience to Build Better Lives - theLoop - March 5th, 2025 [March 5th, 2025]
- Creating a pipeline of talent to feed the growth of Neuroscience: Lessons from Ghana - Myjoyonline - March 5th, 2025 [March 5th, 2025]
- Exclusive: NIH appears to archive policy requiring female animals in studies - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- Roll On Down The Highway 2025 Tour coming to Neuroscience Group Field - WeAreGreenBay.com - February 25th, 2025 [February 25th, 2025]
- STEM organizations host Neuroscience Outreach Fair for local K-12 students - University of Virginia The Cavalier Daily - February 25th, 2025 [February 25th, 2025]
- Adapt or die: Safeguarding the future of diversity and inclusion funding in neuroscience - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- The last two-author neuroscience paper? - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience - Business Wire - February 25th, 2025 [February 25th, 2025]
- Why Firefly Neuroscience, Inc. (AIFF) Is Soaring This Year So Far - Yahoo Finance - February 25th, 2025 [February 25th, 2025]
- Breaking the barrier between theorists and experimentalists - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- Preserving Brain Health and Advancing Neuroscience - University of Miami - February 25th, 2025 [February 25th, 2025]
- Science must step away from nationally managed infrastructure - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- Repurposed Blood Pressure Drug May Treat ADHD - Neuroscience News - February 25th, 2025 [February 25th, 2025]
- How to teach students about science funding - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- Reflecting on 2024: Advancing Neuroscience Research to Improve Neurological Health - National Institute of Neurological Disorders and Stroke - February 25th, 2025 [February 25th, 2025]
- Brains Hidden Circuitry for Risk and Reward Uncovered - Neuroscience News - February 25th, 2025 [February 25th, 2025]
- Why We Keep Exploring Even After Learning the Best Strategy - Neuroscience News - February 25th, 2025 [February 25th, 2025]
- Unlocking Cellular Youth: The Protein That Reverses Aging - Neuroscience News - February 25th, 2025 [February 25th, 2025]
- This paper changed my Life: Bill Newsome reflects on a quadrilogy of classic visual perception studies - The Transmitter: Neuroscience News and... - February 25th, 2025 [February 25th, 2025]
- Roundup: The false association between vaccines and autism - The Transmitter: Neuroscience News and Perspectives - February 3rd, 2025 [February 3rd, 2025]
- Static pay, shrinking prospects fuel neuroscience postdoc decline - The Transmitter: Neuroscience News and Perspectives - February 3rd, 2025 [February 3rd, 2025]
- Stimulating the brain with Damien Fair - The Transmitter: Neuroscience News and Perspectives - February 3rd, 2025 [February 3rd, 2025]
- Unhealthy Diet Linked to Faster Biological Aging in Young Adults - Neuroscience News - February 3rd, 2025 [February 3rd, 2025]
- Bob Smittcamp Family Neuroscience Institute coming to Fresno in 2026 - ABC30 News - February 3rd, 2025 [February 3rd, 2025]
- Norton Neuroscience Institute selected to pilot national Brain Health Navigator program - Norton Healthcare - February 3rd, 2025 [February 3rd, 2025]
- Coding bonus: Bats hippocampal cells log spatial, social cues - The Transmitter: Neuroscience News and Perspectives - February 3rd, 2025 [February 3rd, 2025]
- ADHD and brainwaves: How neuroscience is changing the way we diagnose the condition - PsyPost - February 3rd, 2025 [February 3rd, 2025]
- David Robbe challenges conventional notions of time and memory - The Transmitter: Neuroscience News and Perspectives - February 3rd, 2025 [February 3rd, 2025]
- How the Brain Processes Space and Time - Neuroscience News - February 3rd, 2025 [February 3rd, 2025]
- Using neuroscience to help establish healthier habits | Opinion - South Bend Tribune - February 3rd, 2025 [February 3rd, 2025]
- Solvonis chairman on heavy-hitting M&A in neuroscience sector - ICYMI - Proactive Investors UK - February 3rd, 2025 [February 3rd, 2025]
- New neuroscience research sheds light on distinct patterns of learning and generalization in autistic adults - PsyPost - January 23rd, 2025 [January 23rd, 2025]
- Neuroscientists need to do better at explaining basic mental health research - The Transmitter: Neuroscience News and Perspectives - January 23rd, 2025 [January 23rd, 2025]
- How Severance shows the possibilities of cognitive neuroscience - Fast Company - January 23rd, 2025 [January 23rd, 2025]
- AdventHealth Welcomes New Leadership In Heart and Vascular Services, Neuroscience and Orthopedics - Northwest Georgia News - January 23rd, 2025 [January 23rd, 2025]
- School of Neuroscience and Language Sciences Program recognized with University Exemplary Department or Program Award - Virginia Tech - January 23rd, 2025 [January 23rd, 2025]
- Early Exposure to Violent Media Linked to Teen Antisocial Behavior - Neuroscience News - January 23rd, 2025 [January 23rd, 2025]
- The Real Cognitive Neuroscience Behind Severance - WIRED - January 23rd, 2025 [January 23rd, 2025]
- The 15 most popular psychology and neuroscience studies in 2024 - PsyPost - January 1st, 2025 [January 1st, 2025]
- The 'lizard brain' lie: How neuroscience demolished the greatest mind myth - BBC Science Focus - January 1st, 2025 [January 1st, 2025]
- Revolutionizing Brain Diagnostics with Light and AI - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- How Early Experiences Shape Genes, Brain Health, and Resilience - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- A nation exhausted: The neuroscience of why Americans are tuning out political news - Indiana Capital Chronicle - January 1st, 2025 [January 1st, 2025]
- Lithium Restores Brain Function and Behavior in Autism - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- Partners in Diversity presents the science of belonging: exploring the neuroscience of inclusion - Here is Oregon - January 1st, 2025 [January 1st, 2025]
- Classical vs. Operant Conditioning: The Brain's Memory Tug-of-War - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- The Personality Gap Between Singles and the Partnered - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- The Neuroscience Behind Vermeers Girl and Its Hypnotic Power - ZME Science - January 1st, 2025 [January 1st, 2025]
- Serotonin, GABA, and Dopamine Drive Hunger and Feeding - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- A nation exhausted: The neuroscience of why Americans are tuning out politics - The Conversation - December 23rd, 2024 [December 23rd, 2024]
- UNO Goalie and Neuroscience Grad Shines in Her Athletic and Academic Aspirations - University of Nebraska Omaha - December 23rd, 2024 [December 23rd, 2024]